#tirzepatide
Related Stories (2)
Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery - Reuters
Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery Reuters
April 9, 2026Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial - Reuters
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial Reuters
February 23, 2026Related Pages (2)
Amazon Pharmacy Brings Zepbound's New KwikPen
Amazon AMZN said it would begin offering the Zepbound KwikPen, a multi-dose tirzepatide device developed by Eli Lilly LLY, through its platform. The medication will offer transparent cash-pay pricing
tradingview.com•April 9, 2026
Novo Nordisk’s obesity drug falls short against Eli Lilly’s in trial
Novo Nordisk said on Monday its experimental obesity drug CagriSema did not meet the primary endpoint in a trial designed to show it was non-inferior to competitor Eli Lilly’s tirzepatide in reducing
english.aaj.tv•February 24, 2026